These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 9115588
21. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, Huang MT. Cancer Res; 1997 Apr 15; 57(8):1468-74. PubMed ID: 9108447 [Abstract] [Full Text] [Related]
22. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M, Pazzaglia S, Tanori M, Rebessi S, Di Majo V, Covelli V, Saran A. Mutat Res; 2004 Apr 14; 548(1-2):35-45. PubMed ID: 15063134 [Abstract] [Full Text] [Related]
23. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development. Sung YM, He G, Fischer SM. Cancer Res; 2005 Oct 15; 65(20):9304-11. PubMed ID: 16230392 [Abstract] [Full Text] [Related]
24. The suprabasal expression of alpha 6 beta 4 integrin is associated with a high risk for malignant progression in mouse skin carcinogenesis. Tennenbaum T, Weiner AK, Belanger AJ, Glick AB, Hennings H, Yuspa SH. Cancer Res; 1993 Oct 15; 53(20):4803-10. PubMed ID: 8402665 [Abstract] [Full Text] [Related]
25. Anti-tumor promoting activities of lantadenes on mouse skin tumors and mouse hepatic tumors. Inada A, Nakanishi T, Tokuda H, Nishino H, Sharma OP. Planta Med; 1997 Jun 15; 63(3):272-4. PubMed ID: 9225615 [Abstract] [Full Text] [Related]
26. Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate. Toftgard R, Yuspa SH, Roop DR. Cancer Res; 1985 Nov 15; 45(11 Pt 2):5845-50. PubMed ID: 2414001 [Abstract] [Full Text] [Related]
27. Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Gimenez-Conti IB, Bianchi AB, Fischer SM, Reiners JJ, Conti CJ, Slaga TJ. Cancer Res; 1992 Jun 15; 52(12):3432-5. PubMed ID: 1375869 [Abstract] [Full Text] [Related]
28. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin. Ridd K, Zhang SD, Edwards RE, Davies R, Greaves P, Wolfreys A, Smith AG, Gant TW. Carcinogenesis; 2006 Aug 15; 27(8):1556-66. PubMed ID: 16537558 [Abstract] [Full Text] [Related]
29. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Budunova IV, Perez P, Vaden VR, Spiegelman VS, Slaga TJ, Jorcano JL. Oncogene; 1999 Dec 09; 18(52):7423-31. PubMed ID: 10602501 [Abstract] [Full Text] [Related]
30. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R. Cancer Res; 1999 Feb 01; 59(3):622-32. PubMed ID: 9973210 [Abstract] [Full Text] [Related]
31. Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10. Sundberg JP, Erickson AA, Roop DR, Binder RL. Cancer Res; 1994 Mar 01; 54(5):1344-51. PubMed ID: 7509717 [Abstract] [Full Text] [Related]
32. Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Roop DR, Krieg TM, Mehrel T, Cheng CK, Yuspa SH. Cancer Res; 1988 Jun 01; 48(11):3245-52. PubMed ID: 2452688 [Abstract] [Full Text] [Related]
33. Induction of terminal differentiation-resistant epidermal cells in mouse skin and in papillomas by different initiators during two-stage carcinogenesis. Miller DR, Viaje A, Rotstein J, Aldaz CM, Conti CJ, Slaga TJ. Cancer Res; 1989 Jan 15; 49(2):410-4. PubMed ID: 2491955 [Abstract] [Full Text] [Related]
34. The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells. Chebotaev D, Yemelyanov A, Zhu L, Lavker RM, Budunova I. Oncogene; 2007 May 10; 26(21):3060-8. PubMed ID: 17146443 [Abstract] [Full Text] [Related]
35. The mechanisms of tumor suppressor effect of glucocorticoid receptor in skin. Chebotaev D, Yemelyanov A, Budunova I. Mol Carcinog; 2007 Aug 10; 46(8):732-40. PubMed ID: 17538956 [Abstract] [Full Text] [Related]
36. Constitutive expression of B7-1 (CD80) on mouse keratinocytes does not prevent development of chemically induced skin papillomas and carcinomas. Williams IR, Ort RJ, Daley D, Manning L, Karaoli T, Barnhill RL, Kupper TS. J Immunol; 1996 May 01; 156(9):3382-8. PubMed ID: 8617964 [Abstract] [Full Text] [Related]
37. Reduction in IkappaB kinase alpha expression promotes the development of skin papillomas and carcinomas. Park E, Zhu F, Liu B, Xia X, Shen J, Bustos T, Fischer SM, Hu Y. Cancer Res; 2007 Oct 01; 67(19):9158-68. PubMed ID: 17909021 [Abstract] [Full Text] [Related]
38. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, De Luca LM. Cancer Res; 1995 Jul 01; 55(13):2774-82. PubMed ID: 7540949 [Abstract] [Full Text] [Related]
39. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice. Xian W, Kiguchi K, Imamoto A, Rupp T, Zilberstein A, DiGiovanni J. Cell Growth Differ; 1995 Nov 01; 6(11):1447-55. PubMed ID: 8562483 [Abstract] [Full Text] [Related]